# Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma

> **NCT07315555** · NA · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 90 (estimated)

## Conditions studied

- Community Acquired Pneumonia

## Interventions

- **DIETARY_SUPPLEMENT:** Nigella sativa Oil Capsules (100 mg/kg/day)
- **DIETARY_SUPPLEMENT:** Nigella sativa Oil Capsules (50 mg/kg/day)
- **DRUG:** Fluticasone / Long-Acting Beta-2 Agonist Combination

## Key facts

- **NCT ID:** NCT07315555
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-10-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07315555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07315555, "Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07315555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*